Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Cardiovascular Genetics
Search: search_blue_button Advanced Search
Circulation: Cardiovascular Genetics. 2009;2:379-388
Published online before print May 14, 2009, doi: 10.1161/CIRCGENETICS.108.842849
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
2/4/379    most recent
CIRCGENETICS.108.842849v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayr, M.
Right arrow Articles by Boulanger, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayr, M.
Right arrow Articles by Boulanger, C. M.
Related Collections
Right arrow Apoptosis
Right arrow Pathophysiology
Right arrow Carotid Stenosis
Right arrow Carotid endarterectomy
Right arrow Mechanism of atherosclerosis/growth factors

Original Articles

Proteomics, Metabolomics, and Immunomics on Microparticles Derived From Human Atherosclerotic Plaques

Manuel Mayr, MD, PhD; David Grainger, PhD; Ursula Mayr, MD; Aurelie S. Leroyer, PhD; Guy Leseche, MD; Anissa Sidibe, PhD; Olivier Herbin, MSc; Xiaoke Yin, PhD; Aldrin Gomes, PhD; Bassetti Madhu, PhD; John R. Griffiths, MD; Qingbo Xu, MD, PhD; Alain Tedgui, PhD and Chantal M. Boulanger, PhD

From the Cardiovascular Division (M.M., U.M., A.S., X.Y., Q.X.), King’s BHF Centre of Research Excellence, King’s College London, London, United Kingdom; Department of Medicine (D.G.), Addenbrooke’s Hospital, Cambridge, United Kingdom; Paris-Cardiovascular Research Center (A.S.L., G.L., O.H., A.T., C.M.B.), INSERM U970, Hôpital Européen Georges Pompidou, Université Paris-Descartes, Paris, France; Section of Neurobiology (A.G.), Physiology, and Behavior, University of California, Davis, Calif; Cancer Research UK Cambridge Research Institute (B.M., J.R.G.), Robinson way, Cambridge, United Kingdom.

Correspondence to Manuel Mayr, MD, PhD, Cardiovascular Division, King’s College London, 125 Coldharbour Lane, London SE5 9NU, United Kingdom. E-mail manuel.mayr{at}kcl.ac.uk

Received December 9, 2008; accepted May 8, 2009.

Background— Microparticles (MPs) with procoagulant activity are present in human atherosclerosis, but no detailed information is available on their composition.

Methods and Results— To obtain insights into the role of MPs in atherogenesis, MP proteins were identified by tandem mass spectrometry, metabolite profiles were determined by high-resolution nuclear magnetic resonance spectroscopy, and antibody reactivity was assessed against combinatorial antigen libraries. Plaque MPs expressed surface antigens consistent with their leukocyte origin, including major histocompatibility complex classes I and II, and induced a dose-dependent stimulatory effect on T-cell proliferation. Notably, taurine, the most abundant free organic acid in human neutrophils, which scavenges myeloperoxidase-catalyzed free radicals, was highly enriched in plaque MPs. Moreover, fluorescent labeling of proteins on the MP surface suggested immunoglobulins to be trapped inside, which was confirmed by flow cytometry analysis on permeabilized and nonpermeabilized plaque MPs. Colabeling for CD14 and IgG established that more than 90% of the IgG containing MPs were CD14+, indicating a macrophage origin. Screening against an antigen library revealed that the immunologic profiles of antibodies in MPs were similar to those found in plaques but differed profoundly from antibodies in plasma and unexpectedly, showed strong reactions with oligosaccharide antigens, in particular blood group antigen A.

Conclusions— This study provides the first evidence that immunoglobulins are present within MPs derived from plaque macrophages, that the portfolio of plaque antibodies is different from circulating antibodies in plasma, and that anticarbohydrate antibodies are retained in human atherosclerotic lesions.

Key Words: antigens • atherosclerosis • carotid arteries • plaque • proteins • proteomics


 

CLINICAL PERSPECTIVE

The online-only Data Supplement is available at http://circgenetics.ahajournals.org/cgi/content/full/CIRCGENETICS.108.842849/DC1.